Michel Vandormael
University of Liège
7 Papers
133 Citations
Michel Vandormael is an academic researcher from University of Liège. The author has contributed to research in topics: Heart rate & Pulmonary wedge pressure. The author has an hindex of 6, co-authored 7 publications.
Chat about Author
Papers
Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): a first-in-human multicenter pilot trial.
Xiaoshun Liu,Yanming Huang,Claude Hanet,Michel Vandormael,Victor Legrand,Joseph Dens,Jean Luc Vandenbossche,Luc Missault,Christiaan J. Vrints,Ivan De Scheerder +9 more
TL;DR: The feasibility and safety of the implantation of a dexamethasone‐eluting stent and its effect on in‐stent neointimal hyperplasia were demonstrated and were lower in the unstable angina pectoris patients compared to the stable patients.
Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.
TL;DR: The hemodynamic effects of flecainide acetate, a new class I antiarrhythmic agent, were studied in 10 patients with coronary heart disease as discussed by the authors, and the drug was injected intravenously at a dose of 2 mg/kg over 30 minutes.
59
Hemodynamic effects of intravenous diltiazem with impaired left ventricular function
TL;DR: Intravenous diltiazem may be used safely in patients with heart failure, however, in view of the marked bradycardic effects seen in some cases, heart rate should be carefully monitored.
30
Haemodynamic effects of intravenous diltiazem at rest and exercise in patients with coronary artery disease.
TL;DR: It is indicated that intravenous diltiazem is a potentially useful agent for the treatment of angina by reducing myocardial oxygen demand at rest and by improving left ventricular performances on exercise.
17
Comparative haemodynamic effects of intravenous flecainide in patients with and without heart failure and with and without beta-blocker therapy.
TL;DR: Fleckcainide exerts negative inotropic effects that are maximal at the end of infusion and may be of importance in patients with established left ventricular dysfunction.
15